Royalty Pharma plc RPRX
Set alert
67.18 USD +1.25 +1.90%
At close · Oct 30
67.60 +0.42 +0.63%
After hours · Oct 30, 5:13 PM ET
66.40 Day range 67.71
36.94 52-week range 67.18
- YTD
- +73.86%
- 1 year
- +81.86%
- Open
- 67.00
- Prev close
- 65.93
- Mkt cap
- 38.82B
- Vol
- 4.66M
- Avg vol
- 3.04M
- EPS
- 1.88
- P/E
- 35.73
- Div yield
- 1.43%
More statistics
- Low
- 66.40
- High
- 67.71
- Forward P/E
- 11.56
- Beta
- 0.41
- Short ratio
- 4.30
- Inst. own
- 88.44%
- Dividend
- 0.94
- Ex-div date
- Nov 12, 2026
- Earnings
- Nov 4, 2026
- 50-d avg
- 60.15
- 200-d avg
- 53.09
- 1y target
- 65.38
MAX chart
Events in this range
- Sep 14, 2020Dividend: 0.15
- Nov 19, 2020Dividend: 0.15
- Feb 18, 2021Dividend: 0.17
- May 19, 2021Dividend: 0.17
- Aug 19, 2021Dividend: 0.17
- Nov 18, 2021Dividend: 0.17
- Feb 17, 2022Dividend: 0.19
- May 19, 2022Dividend: 0.19
- Aug 18, 2022Dividend: 0.19
- Nov 17, 2022Dividend: 0.19
- Dec 15, 2022Dividend: 0.19
- Feb 15, 2023Dividend: 0.2
- May 18, 2023Dividend: 0.2
- Aug 17, 2023Dividend: 0.2
- Nov 16, 2023Dividend: 0.2
- Feb 15, 2024Dividend: 0.21
- May 16, 2024Dividend: 0.21
- Aug 16, 2024Dividend: 0.21
- Nov 15, 2024Dividend: 0.21
- Feb 20, 2025Dividend: 0.22
- Feb 21, 2025Dividend: 0.22
- May 16, 2025Dividend: 0.22
- Aug 6, 2025Earnings: 1.14; estimate 1.03; surprise 10.68%
- Aug 15, 2025Dividend: 0.22
- Nov 5, 2025Earnings: 1.17; estimate 0.994; surprise 17.71%
- Nov 14, 2025Dividend: 0.22
- Feb 11, 2026Earnings: 1.46; estimate 1.29; surprise 13.18%
- Feb 20, 2026Dividend: 0.235
- May 6, 2026Earnings: 1.3; estimate 1.21; surprise 7.44%
- May 7, 2026Rating: JP Morgan · Overweight → Overweight
- May 7, 2026Rating: Citigroup · Buy → Buy
- May 15, 2026Dividend: 0.235
- Jul 13, 2026Rating: TD Cowen · Buy → Buy
- Aug 5, 2026Earnings: 1.32; estimate 1.27; surprise 3.94%
- Aug 7, 2026Rating: JP Morgan · Overweight → Overweight
- Aug 14, 2026Dividend: 0.235
- Sep 8, 2026Rating: TD Cowen · Buy → Buy
- Oct 7, 2026Rating: Morgan Stanley · Overweight → Overweight
- Nov 4, 2026Earnings: —; estimate 1.18; surprise —%
Signals (147)
| Name | Date | Ago |
|---|---|---|
| MACD: Buy Signal | Oct 26, 2026 | 6 days ago |
| RSI: Overbought | Oct 26, 2026 | 6 days ago |
| SMA: Bullish | Oct 12, 2026 | 2 weeks ago |
| SMA: Bearish | Sep 7, 2026 | 1 month ago |
| MACD: Sell Signal | Sep 7, 2026 | 1 month ago |
| MACD: Buy Signal | Aug 17, 2026 | 2 months ago |
| RSI: Overbought | Aug 17, 2026 | 2 months ago |
| MACD: Sell Signal | Aug 3, 2026 | 3 months ago |
| RSI: Overbought | Jun 22, 2026 | 4 months ago |
| RSI: Overbought | Jan 26, 2026 | 9 months ago |
| MACD: Buy Signal | Jan 19, 2026 | 9 months ago |
| MACD: Sell Signal | Jan 12, 2026 | 9 months ago |
| SMA: Bullish | Jan 5, 2026 | 10 months ago |
| MACD: Buy Signal | Jan 5, 2026 | 10 months ago |
| SMA: Bearish | Dec 29, 2025 | 10 months ago |
| MACD: Sell Signal | Dec 22, 2025 | 10 months ago |
| RSI: Overbought | Nov 24, 2025 | 11 months ago |
| RSI: Overbought | Nov 10, 2025 | 11 months ago |
| MACD: Buy Signal | Nov 3, 2025 | 12 months ago |
| SMA: Bullish | Oct 13, 2025 | 1 year ago |
| SMA: Bearish | Aug 25, 2025 | 1 year ago |
| MACD: Sell Signal | Aug 25, 2025 | 1 year ago |
| RSI: Overbought | Jul 28, 2025 | 1 year ago |
| RSI: Overbought | Jun 30, 2025 | 1 year ago |
| MACD: Buy Signal | Jun 9, 2025 | 1 year ago |
| SMA: Bullish | May 26, 2025 | 1 year ago |
| SMA: Bearish | May 19, 2025 | 1 year ago |
| MACD: Sell Signal | May 19, 2025 | 1 year ago |
| MACD: Buy Signal | May 12, 2025 | 1 year ago |
| SMA: Bullish | Apr 28, 2025 | 1 year ago |
| SMA: Bearish | Apr 21, 2025 | 1 year ago |
| MACD: Sell Signal | Apr 21, 2025 | 1 year ago |
| SMA: Bullish | Apr 14, 2025 | 1 year ago |
| SMA: Bearish | Mar 24, 2025 | 1 year ago |
| RSI: Overbought | Mar 17, 2025 | 1 year ago |
| RSI: Overbought | Feb 10, 2025 | 1 year ago |
| SMA: Bullish | Jan 6, 2025 | 1 year ago |
| SMA: Bullish | Jan 6, 2025 | 1 year ago |
| MACD: Buy Signal | Jan 6, 2025 | 1 year ago |
| MACD: Sell Signal | Oct 28, 2024 | 2 years ago |
| SMA: Bearish | Oct 21, 2024 | 2 years ago |
| SMA: Bearish | Oct 14, 2024 | 2 years ago |
| SMA: Bullish | Oct 7, 2024 | 2 years ago |
| SMA: Bullish | Oct 7, 2024 | 2 years ago |
| SMA: Bearish | Sep 30, 2024 | 2 years ago |
| SMA: Bearish | Sep 30, 2024 | 2 years ago |
| SMA: Bullish | Sep 23, 2024 | 2 years ago |
| SMA: Bullish | Sep 23, 2024 | 2 years ago |
| SMA: Bearish | Sep 9, 2024 | 2 years ago |
| SMA: Bearish | Sep 9, 2024 | 2 years ago |
| SMA: Bullish | Aug 26, 2024 | 2 years ago |
| SMA: Bullish | Aug 12, 2024 | 2 years ago |
| SMA: Bearish | Aug 5, 2024 | 2 years ago |
| SMA: Bearish | Aug 5, 2024 | 2 years ago |
| SMA: Bullish | Jul 22, 2024 | 2 years ago |
| MACD: Buy Signal | Jul 22, 2024 | 2 years ago |
| SMA: Bullish | Jul 15, 2024 | 2 years ago |
| MACD: Sell Signal | Apr 15, 2024 | 2 years ago |
| SMA: Bearish | Apr 8, 2024 | 2 years ago |
| SMA: Bearish | Apr 1, 2024 | 2 years ago |
| SMA: Bullish | Feb 5, 2024 | 2 years ago |
| SMA: Bearish | Jan 29, 2024 | 2 years ago |
| SMA: Bullish | Jan 15, 2024 | 2 years ago |
| SMA: Bullish | Jan 8, 2024 | 2 years ago |
| SMA: Bearish | Jan 1, 2024 | 2 years ago |
| SMA: Bullish | Dec 18, 2023 | 2 years ago |
| SMA: Bearish | Dec 11, 2023 | 2 years ago |
| SMA: Bullish | Nov 27, 2023 | 2 years ago |
| SMA: Bearish | Nov 6, 2023 | 2 years ago |
| SMA: Bullish | Oct 30, 2023 | 3 years ago |
| MACD: Buy Signal | Oct 30, 2023 | 3 years ago |
| RSI: Oversold | Oct 23, 2023 | 3 years ago |
| MACD: Sell Signal | Sep 11, 2023 | 3 years ago |
| RSI: Oversold | Sep 11, 2023 | 3 years ago |
| MACD: Buy Signal | Aug 21, 2023 | 3 years ago |
| MACD: Sell Signal | Aug 14, 2023 | 3 years ago |
| RSI: Oversold | Aug 14, 2023 | 3 years ago |
| MACD: Buy Signal | Aug 7, 2023 | 3 years ago |
| RSI: Oversold | Jun 19, 2023 | 3 years ago |
| RSI: Oversold | May 22, 2023 | 3 years ago |
| SMA: Bearish | Apr 24, 2023 | 3 years ago |
| SMA: Bullish | Apr 3, 2023 | 3 years ago |
| RSI: Oversold | Mar 6, 2023 | 3 years ago |
| MACD: Sell Signal | Dec 12, 2022 | 3 years ago |
| SMA: Bearish | Dec 5, 2022 | 3 years ago |
| SMA: Bearish | Dec 5, 2022 | 3 years ago |
| SMA: Bullish | Nov 7, 2022 | 3 years ago |
| MACD: Buy Signal | Nov 7, 2022 | 3 years ago |
| SMA: Bearish | Oct 31, 2022 | 4 years ago |
| SMA: Bullish | Oct 24, 2022 | 4 years ago |
| SMA: Bullish | Oct 24, 2022 | 4 years ago |
| SMA: Bearish | Sep 19, 2022 | 4 years ago |
| SMA: Bearish | Sep 12, 2022 | 4 years ago |
| MACD: Sell Signal | Sep 12, 2022 | 4 years ago |
| SMA: Bullish | Sep 5, 2022 | 4 years ago |
| SMA: Bearish | Aug 22, 2022 | 4 years ago |
| SMA: Bullish | Jun 20, 2022 | 4 years ago |
| SMA: Bullish | Jun 20, 2022 | 4 years ago |
| MACD: Buy Signal | Jun 20, 2022 | 4 years ago |
| SMA: Bearish | Jun 13, 2022 | 4 years ago |
| MACD: Sell Signal | Jun 13, 2022 | 4 years ago |
| SMA: Bearish | May 30, 2022 | 4 years ago |
| SMA: Bullish | May 23, 2022 | 4 years ago |
| SMA: Bullish | May 23, 2022 | 4 years ago |
| SMA: Bearish | May 16, 2022 | 4 years ago |
| SMA: Bullish | May 9, 2022 | 4 years ago |
| SMA: Bearish | May 2, 2022 | 4 years ago |
| SMA: Bearish | May 2, 2022 | 4 years ago |
| SMA: Bullish | Mar 28, 2022 | 4 years ago |
| SMA: Bullish | Mar 28, 2022 | 4 years ago |
| MACD: Buy Signal | Mar 28, 2022 | 4 years ago |
| SMA: Bearish | Mar 21, 2022 | 4 years ago |
| SMA: Bearish | Mar 21, 2022 | 4 years ago |
| SMA: Bullish | Mar 14, 2022 | 4 years ago |
| SMA: Bullish | Mar 14, 2022 | 4 years ago |
| MACD: Sell Signal | Feb 28, 2022 | 4 years ago |
| SMA: Bearish | Feb 21, 2022 | 4 years ago |
| SMA: Bearish | Feb 14, 2022 | 4 years ago |
| SMA: Bullish | Jan 24, 2022 | 4 years ago |
| SMA: Bullish | Jan 24, 2022 | 4 years ago |
| SMA: Bearish | Jan 17, 2022 | 4 years ago |
| SMA: Bearish | Jan 10, 2022 | 4 years ago |
| SMA: Bullish | Dec 20, 2021 | 4 years ago |
| SMA: Bullish | Dec 20, 2021 | 4 years ago |
| SMA: Bearish | Nov 29, 2021 | 4 years ago |
| SMA: Bearish | Nov 29, 2021 | 4 years ago |
| SMA: Bullish | Nov 8, 2021 | 4 years ago |
| SMA: Bullish | Oct 25, 2021 | 5 years ago |
| MACD: Buy Signal | Oct 25, 2021 | 5 years ago |
| SMA: Bearish | Oct 18, 2021 | 5 years ago |
| SMA: Bullish | Oct 11, 2021 | 5 years ago |
| MACD: Sell Signal | Jul 5, 2021 | 5 years ago |
| SMA: Bearish | Jun 21, 2021 | 5 years ago |
| SMA: Bearish | Jun 7, 2021 | 5 years ago |
| MACD: Buy Signal | Jun 7, 2021 | 5 years ago |
| SMA: Bullish | May 31, 2021 | 5 years ago |
| SMA: Bullish | May 31, 2021 | 5 years ago |
| SMA: Bearish | Mar 22, 2021 | 5 years ago |
| SMA: Bullish | Mar 8, 2021 | 5 years ago |
| SMA: Bearish | Mar 1, 2021 | 5 years ago |
| MACD: Sell Signal | Mar 1, 2021 | 5 years ago |
| SMA: Bearish | Jan 25, 2021 | 5 years ago |
| SMA: Bullish | Nov 23, 2020 | 5 years ago |
| SMA: Bearish | Nov 16, 2020 | 5 years ago |
| SMA: Bullish | Nov 9, 2020 | 5 years ago |
| SMA: Bearish | Oct 12, 2020 | 6 years ago |
| SMA: Bullish | Sep 28, 2020 | 6 years ago |
Key statistics
- Market cap
- 38.82B
- Enterprise value
- 40.44B
- Trailing P/E
- 35.73
- Forward P/E
- 11.56
- PEG ratio
- 1.54
- Price / sales
- 15.31
- Price / book
- 4.38
- EPS (TTM)
- 1.88
- Beta
- 0.41
- Dividend yield
- 1.43%
- Payout ratio
- 48.40%
- Profit margin
- 32.02%
- Revenue (TTM)
- 2.54B
- Revenue growth
- 16.50%
- Free cash flow
- -1.20B
- Total cash
- 836.99M
- Total debt
- 8.96B
- Return on equity
- 13.96%
- Shares outstanding
- 445.28M
- Short % of float
- 2.92%
- 50-day average
- 60.15
- 200-day average
- 53.09
Analyst view
Consensus: strong buy
Strong buy
Price target (mean) 65.38 -2.7% downside
Now 67.18
- Target (low)
- 61.00
- Target (mean)
- 65.38
- Target (high)
- 70.00
Ratings (0m) 8 7 buy · 1 hold · 0 sell
- Strong buy2
- Buy5
- Hold1
- Sell0
- Strong sell0
Next earnings
Nov 4, 2026
Expected Nov 4, 2026. Consensus EPS estimate 1.18.
Financials — quick view
RPRX Revenue — quarterly 674.14M
RPRX Net income — quarterly 17.88M
RPRX EPS — quarterly 0.04
Earnings
| Report date | Quarter ending | EPS estimate | EPS reported | Surprise | Surprise % |
|---|---|---|---|---|---|
| Nov 4, 2026 | Sep 30, 2026 | 1.18 | — | — | — |
| Aug 5, 2026 | Jun 30, 2026 | 1.27 | 1.32 | +0.05 | +3.94% |
| May 6, 2026 | Mar 31, 2026 | 1.21 | 1.30 | +0.09 | +7.44% |
| Feb 11, 2026 | Dec 31, 2025 | 1.29 | 1.46 | +0.17 | +13.18% |
| Nov 5, 2025 | Sep 30, 2025 | 0.994 | 1.17 | +0.18 | +17.71% |
| Aug 6, 2025 | Jun 30, 2025 | 1.03 | 1.14 | +0.11 | +10.68% |
Upgrades / downgrades
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Oct 7, 2026 | Morgan Stanley | main | Overweight | Overweight |
| Sep 8, 2026 | TD Cowen | main | Buy | Buy |
| Aug 7, 2026 | JP Morgan | main | Overweight | Overweight |
| Jul 13, 2026 | TD Cowen | main | Buy | Buy |
| May 7, 2026 | Citigroup | main | Buy | Buy |
| May 7, 2026 | JP Morgan | main | Overweight | Overweight |
About Royalty Pharma plc
Royalty Pharma plc operates as a buyer of biopharmaceutical royalties and a funder of innovation in the biopharmaceutical industry in the United States. Its portfolio consists of royalties on approximately 35 marketed therapies and 20 development-stage product candidates that address various therapeutic areas, such as rare disease, oncology, neuroscience, infectious disease, hematology, and diabetes. The company has research and development funding collaboration to advance the development of JNJ-4804, an investigational medicine for autoimmune diseases. The company was founded in 1996 and is based in New York, New York.
- Sector
- Healthcare
- Industry
- Biotechnology
- Country
- United States
- Website
- royaltypharma.com
News
- Unveiling Royalty Pharma (RPRX) Q3 Outlook: Wall Street Estimates for Key Metrics
- Should You Buy Royalty Pharma Stock Before Nov. 4?
- Forget Biotech's Binary Bets: This Dividend Stock Collects Royalties on Blockbusters Instead
- 3 Reasons Royalty Pharma Is a Dividend Stock You Never Have to Sell
- BioAge Labs (NASDAQ:BIOA) and Royalty Pharma (NASDAQ:RPRX) Critical Comparison
- Royalty Pharma declares fourth quarter 2026 dividend
- If You Invested $1000 In Royalty Pharma Stock 15 Years Ago, You Would Have This Much Today
- Royalty Pharma to announce third quarter 2026 financial results on November 4, 2026
- Why Royalty Pharma (RPRX) is Poised to Beat Earnings Estimates Again
- Morgan Stanley Maintains Overweight on Royalty Pharma, Raises Price Target to $67
Your note
Sign in to keep a note on RPRX — it syncs with the Stock Master app.
Insider holders
| Insider | Relation | Latest transaction | Date | Shares held |
|---|---|---|---|---|
| BASSLER BONNIE L | Director | Stock Award(Grant) | Sep 29, 2026 | 79,823 |
| COYNE TERRANCE P | Chief Financial Officer | Sale | Aug 12, 2026 | 0 |
| DESOUZA ERROL B | Director | Stock Award(Grant) | May 12, 2025 | 81,352 |
| ENGELBERT CATHERINE M. | Director | Stock Award(Grant) | Jun 4, 2026 | 55,673 |
| FERNANDEZ HENRY A | Director | Stock Award(Grant) | Jun 29, 2025 | 123,524 |
| HITE CHRISTOPHER | Officer | Sale | Sep 21, 2026 | 0 |
Institution ownership
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| Morgan Stanley | 9.64% | 42,931,597 | 2.88B | Jun 29, 2026 |
| Capital International Investors | 7.92% | 35,273,770 | 2.37B | Jun 29, 2026 |
| Blackrock Inc. | 6.25% | 27,832,977 | 1.87B | Jun 29, 2026 |
| FMR, LLC | 5.51% | 24,513,814 | 1.65B | Jun 29, 2026 |
| State Street Corporation | 2.77% | 12,338,229 | 828.88M | Jun 29, 2026 |
| Price (T.Rowe) Associates Inc | 2.51% | 11,193,657 | 751.99M | Jun 29, 2026 |
Fund ownership
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| NEW PERSPECTIVE FUND | 4.34% | 19,337,535 | 1.30B | Sep 29, 2026 |
| Capital Income Builder | 1.67% | 7,427,586 | 498.99M | Sep 29, 2026 |
| Growth Fund of America | 1.52% | 6,747,312 | 453.28M | Sep 29, 2026 |
| MORGAN STANLEY INSTITUTIONAL FUND INC-GROWTH PORTFOLIO | 1.10% | 4,910,932 | 329.92M | Jun 29, 2026 |
| VANGUARD INDEX FUNDS-Vanguard Extended Market Index Fund | 1.00% | 4,471,210 | 300.38M | Jun 29, 2026 |
| TR PRICE-Price (T.Rowe) U.S. Value Equity Trust | 0.95% | 4,232,023 | 284.31M | Jun 29, 2026 |